|

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

RECRUITINGN/ASponsored by The Cooper Health System
Actively Recruiting
PhaseN/A
SponsorThe Cooper Health System
Started2022-02-01
Est. completion2026-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05203328

Summary

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* age\>18 years
* patient undergoing EBUS bronchoscopy with moderate conscious sedation.

Exclusion Criteria:

* subjects with previous nasal surgeries
* subjects with oxygen saturation \<90% on room air prior to procedure
* subjects who are pregnant
* subjects with known facial fractures or recent facial trauma
* subjects on any anticoagulation that cannot be discontinued prior to the procedure

Conditions2

CancerLung Cancer

Locations1 site

Cooper University Hospital
Camden, New Jersey, 08103
Wissam Abouzgheib, MD800-826-6737abouzgheib-wissam@cooperhealth.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.